20 Participants NeededMy employer runs this trial

Poly-L-Lactic Acid for Pelvic Organ Prolapse

CK
DU
Overseen ByDuke Urogynecology Clinical Research Coordinators

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores a new treatment for pelvic organ prolapse (POP) using poly-L-lactic acid (PLLA), a material safely used in skin treatments. POP can cause symptoms like a vaginal bulge or pelvic pressure, and current treatments often involve surgery, which may affect sexual function. The trial compares PLLA injections to a placebo to determine if it can strengthen vaginal tissue and improve sexual function without surgery. Women with stage 2 cystocele (a type of POP) who experience and are bothered by a vaginal bulge might be suitable candidates for this study.

As an unphased trial, this study provides a unique opportunity to investigate a non-surgical treatment option for POP.

Will I have to stop taking my current medications?

If you are on prescription anticoagulation therapy that cannot be safely stopped, you may not be eligible for the trial. Also, if you are using other treatments for prolapse, like a pessary, you would need to stop these during the study.

What prior data suggests that poly-L-lactic acid is safe for treating pelvic organ prolapse?

Research has shown that Poly-L-Lactic Acid (PLLA) is generally safe for humans. For over ten years, it has been used safely in skin treatments. Studies on PLLA for other purposes have also monitored its safety and reported positive results. Although using PLLA for pelvic organ prolapse (POP) is new, its safety in other treatments suggests it could be safe here as well. Side effects have been minor, with no major issues commonly reported. This information should reassure those considering joining the trial.12345

Why are researchers excited about this trial?

Unlike the standard treatments for pelvic organ prolapse, which often include surgical options or pessaries, Poly-L-Lactic Acid (PLLA) offers a non-surgical approach. PLLA, commonly known by the brand name Sculptra, works by stimulating the body's own collagen production to strengthen the tissues in the pelvic area. This innovative mechanism not only aims to provide support but also potentially improves the durability and resilience of the vaginal wall without invasive procedures. Researchers are excited about PLLA because it may offer a less invasive, long-lasting solution that enhances tissue structure, potentially reducing the need for frequent interventions.

What evidence suggests that poly-L-lactic acid might be an effective treatment for pelvic organ prolapse?

Research has shown that Poly-L-Lactic Acid (PLLA) might help treat pelvic organ prolapse (POP). PLLA has been used successfully in other fields, such as skin care, to promote tissue regeneration. One study found that a patch made with PLLA significantly improved organ positioning in cases of anterior pelvic prolapse. This suggests that PLLA might strengthen tissues, which could benefit POP treatment. PLLA's established safety in other applications adds to its potential for this condition. Although specific studies on POP remain limited, early results are promising for tissue regeneration. Participants in this trial will receive either PLLA injections or control injections to assess its effectiveness for POP.12367

Who Is on the Research Team?

CK

Cassandra Kisby, MD MS FACOG FACS

Principal Investigator

Duke University

Are You a Good Fit for This Trial?

This trial is for women over 21 who have stage II pelvic organ prolapse (specifically a bulge in the front vaginal wall) that bothers them. Participants must be able to read or understand English and either be abstinent, using contraception, or postmenopausal.

Inclusion Criteria

* Positive response to PFDI-20 question 3: Do you usually have a bulge or something falling out that you can see or feel in the vaginal area?
I am bothered by my symptoms, even if only a little.
I am abstinent, using birth control, or postmenopausal.
See 4 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive three injections of PLLA or placebo, one per month, in the tissues of the front wall of the vagina

3 months
3 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment, including adverse events and pelvic organ prolapse quantification

6 months
Multiple visits (in-person) at 1, 2, 6, and 9 months

What Are the Treatments Tested in This Trial?

Interventions

  • Poly-L-Lactic Acid

Trial Overview

The study compares injections of poly-L-lactic acid (PLLA), a substance used to stimulate tissue growth, with placebo (sterile water) injections in women with anterior vaginal wall prolapse. It aims to see if PLLA can safely improve symptoms and sexual function.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Placebo Group

Group I: PLLA (Sculptra) InjectionExperimental Treatment1 Intervention
Group II: Control InjectionPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Cassandra Kisby

Lead Sponsor

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Collaborator

Trials
508
Recruited
1,090,000+

Citations

Poly-L-Lactic Acid for Vulvovaginal Tissue Regeneration

Our study will compare intravaginal injection of PLLA vs. placebo in women with stage 2 cystocele and investigate safety and preliminary efficacy of PLLA. Prior ...

2.

pubmed.ncbi.nlm.nih.gov

pubmed.ncbi.nlm.nih.gov/35831453/

Six-year follow-up outcomes of the P(LLA-CL)/Fg bio-patch ...

Anterior pelvic reconstruction surgery with a P(LLA-CL)/Fg bio-patch demonstrated significant improvements in anatomical correction of anterior pelvic prolapse.

Poly-L-Lactic Acid for Pelvic Organ Prolapse

This randomized controlled trial has the potential to shift the paradigm of prolapse management from surgical reconstruction to regeneration.

New Proposed Treatments for Pelvic Organ Prolapse - PMC

Unfortunately, the absorbable meshes or biological grafts do not improve surgical outcomes compared to the native tissue POP repair [5, 6]. In addition, patient ...

Ascorbic acid 2-phosphate-releasing poly-l-lactide-co-epsilon ...

Abstract. Pelvic organ prolapse (POP) significantly impacts women's health and quality of life. There is a critical need for alternative biomaterials for s.

Tissue-engineered repair material for pelvic floor dysfunction

PLGA scaffold is approved by the FDA (U.S. Food and Drug Administration, United States)/EMA (European Medicines Agency) and extensively explored ...

Ascorbic acid 2-phosphate-releasing poly-l-lactide-co-epsilon ...

Pelvic organ prolapse (POP) significantly impacts women's health and quality of life. There is a critical need for alternative biomaterials for surgical POP ...